VeriMombaicalin hamilelikte güvenli mi?
No harmonised CLP reproductive classification (no H360/H361) and no SCCS/CIR safety assessment flagging reproductive hazard were identified. PubMed/PMC studies of baicalin in pregnancy models report pharmacologic/modulatory effects (some protective in LPS models) rather than consistent reproductive toxicity, so by source-priority standards there is no evidence requiring a hazard flag. Sources: PubMed/PMC animal studies and regulatory databases (PubChem/KEGG, EWG).
Pregnancy-safe products containing baicalin
Related ingredients
Frequently asked questions
- baicalin hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (no H360/H361) and no SCCS/CIR safety assessment flagging reproductive hazard were identified. PubMed/PMC studies of baicalin in pregnancy models report pharmacologic/modulatory effects (some protective in LPS models) rather than consistent reproductive toxicity, so by source-priority standards there is no evidence requiring a hazard flag. Sources: PubMed/PMC animal studies and regulatory databases (PubChem/KEGG, EWG).
- baicalin emzirirken güvenli mi?
- No regulatory or authoritative safety assessment (CIR, SCCS, harmonised CLP) indicates lactation/transfer hazards, and published studies do not provide clear evidence of adverse effects via lactation. No data found demonstrating transfer in human milk or adverse pup outcomes via lactation in relevant high-quality studies; therefore default score is 0. (See cited studies and database entries.)
- baicalin bebek cildi için güvenli mi?
- No evidence of a reproductive/developmental hazard specific to infants (h=0). Mechanistic evidence for a reproductive mechanism was not identified (m=0). For exposure (e) I increased the score by +1 for baby skin because baicalin is a small natural flavonoid glycoside with measurable biological activity in vivo (so it is not completely non‑absorbable); topical dermal absorption from cosmetics is expected to be low for the parent compound but infant skin has a higher surface‑area‑to‑weight and immature barrier, so exposure for 0–3 y is assigned 1. No infant‑specific toxicokinetic data were found to justify higher exposure or hazard scores.
- VeriMom baicalin nasıl puanlıyor?
- VeriMom baicalin'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte baicalin yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.